Business Context and Reporting Period
Company: Merit Medical Systems, Inc. (MMSI)
Filing Type: Form 8-K (Current Report)
Date of Report: January 13, 2025
Reporting Period: Preliminary unaudited revenue for the year ended December 31, 2024.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The report serves as a notification that preliminary unaudited revenue figures for the full year 2024 have been issued in a press release (Exhibit 99.1), which is incorporated by reference. The text notes the use of non-GAAP financial measures in the press release but does not list the specific metrics or reconciliations within the 8-K body.
Material Changes
No specific material changes or comparative financial data versus prior periods are detailed in the text of this filing. The document indicates that the preliminary revenue information is based on current expectations and may be adjusted following customary financial review and audit procedures.
Guidance, Outlook, and Management Commentary
- Upcoming Announcement: The Company plans to announce its fourth quarter and full-year 2024 financial results on February 25, 2025.
- Future Guidance: Fiscal year 2025 guidance will be issued on February 25, 2025.
- Regulatory Note: Information in this report is furnished pursuant to Regulation FD and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the specific preliminary revenue number for the year ended December 31, 2024.
- Verify the reconciliation of non-GAAP financial measures to GAAP measures in the press release.
- Monitor the February 25, 2025 announcement for finalized Q4 and full-year 2024 results and FY2025 guidance.
- Confirm if the preliminary revenue figures are adjusted after the completion of audit procedures.